Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
£ 0.01
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks.
Data is available to registered users only
Buy
Sell